Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118126972A reveals enhanced enzyme mutant for (S)-NBHP production offering superior acid resistance and reduced processing costs for pharmaceutical supply chains.
Patent CN101659642B details a novel phase-transfer catalytic route for sulfonylureas, offering safer agrochemical manufacturing and significant cost reduction.
Patent CN115677546B reveals a novel chiral synthesis route for Florfenicol intermediates, offering higher yields and eliminating toxic copper waste for reliable supply chains.
High-yield catalytic method for pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers.
Patent CN114634957B reveals enzymatic synthesis for 4AA. Offers cost reduction and supply chain reliability for API manufacturing partners.
Patent CN109265403A reveals imidazole hydrochloride catalysis for high-purity benzimidazole intermediates, offering cost reduction and scalable manufacturing solutions.
Green enzyme catalysis process ensures high purity and stability for cosmetic applications with reduced environmental impact and supply chain reliability.
Patent CN100347149C reveals a breakthrough solid catalyst method for valienamine production, offering high yields and streamlined purification for API manufacturers.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Patent CN113121338A reveals a green photocatalytic method for alpha-hydroxylation using air and visible light, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel aqueous phase synthesis for cefixime intermediate reduces VOCs and waste. High purity pharmaceutical intermediates supplier offering green manufacturing solutions.
Patent CN106824269A reveals efficient ionic liquid catalysis for high-purity pyrazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111961011B reveals a metal-free visible light method for benzothiazole derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN107417726B reveals PC-Phos ligand enabling high-yield asymmetric cyclization. Delivers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing.
Patent CN112358389B reveals a green LED-driven route for 2-MNQ. Eliminate chromium waste and reduce costs in vitamin K3 manufacturing with our scalable photochemical technology.
Patent CN108623564B reveals a high-yield vanadium-catalyzed route for Dextro-Rabeprazole. Discover cost-effective manufacturing and superior enantioselectivity for your supply chain.
Patent CN113061630A reveals a multi-enzyme cascade for 4-HIL synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102942451A details a green method for 1,2-diol production using recyclable selenium polymers, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis method for diaryl macrocyclic crown ethers offers higher yields and simplified operations for supramolecular chemistry and specialty chemical manufacturing supply chains.
Patent CN101613280B reveals a high-purity synthesis route for felodipine intermediates using a secondary amine and quinoline carboxylic acid catalyst system, offering significant cost and purity advantages.